| Mrs Jean Coughlin Richtsmeier, MS, CCC-SLP | |
|
1111 N Mission St, Ste B, Wenatchee, WA 98801-6705 | |
| (509) 888-2505 | |
| (509) 888-2507 |
| Full Name | Mrs Jean Coughlin Richtsmeier |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1111 N Mission St, Wenatchee, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104957752 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL60047991 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jean Coughlin Richtsmeier, MS, CCC-SLP Po Box 2994, Wenatchee, WA 98807-2994 Ph: (509) 888-3062 | Mrs Jean Coughlin Richtsmeier, MS, CCC-SLP 1111 N Mission St, Ste B, Wenatchee, WA 98801-6705 Ph: (509) 888-2505 |
News Archive
A unique survey of African American breast cancer survivors at heightened risk for hereditary breast cancer has found the majority do not believe they have an increased chance of developing the cancer again.
Patients with severe ischemic heart disease and heart failure can benefit from a new treatment in which stem cells found in bone marrow are injected directly into the heart muscle, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session.
Currently, there is no treatment to halt the progression of Huntington's disease (HD), a fatal genetic disorder that slowly robs sufferers of their physical and mental abilities. Now, researchers at University of California, San Diego School of Medicine have discovered that an existing compound, previously tested for diabetes, offers hope for slowing HD and its symptoms.
Large-scale computer simulations have pinpointed a tiny change in molecular structure that could account for drug resistance in Streptomices pneumoniae, the organism that causes childhood pneumonia and claims 3.5 million lives a year, mainly in developing countries.
Brookstone Pharmaceuticals, an emerging specialty pharmaceutical company, announced today its decision to change the name of the company to Acella Pharmaceuticals, LLC. This decision has been made to create a company image and brand that more accurately mirrors our commitment to "Accelerating the Health Care Solution" by bringing quality affordable products to customers and patients. Mark Pugh, CEO states, "As we have grown over the last few years, we have evolved into a more integrated pharmaceutical company.
› Verified 2 days ago
Kevin Wayne Schell, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1201 S Miller St, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Alexis Mary Elwood, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1500 S Mission St, Wenatchee, WA 98801 Phone: 509-888-2505 | |
Erica Batjer, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1201 S Miller St, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Tonya Lee Asmussen, MA CF SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Mrs. Elizabeth Anne Mclaughlin, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 112 Elliott Ave S, Wenatchee, WA 98801 Phone: 509-663-7117 | |
Philip Gregg, MA, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 224 Methow St, Wenatchee, WA 98801 Phone: 509-663-5710 |